Clinical Trials Browser

Has results × Biliary Tract Neoplasms × Capecitabine × Clear all

NCT03111732 2021-12-03

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Phase 2 Completed

11 enrolled 16 charts

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Cholangiocarcinoma

NCT03093870 2021-08-03

TreeTopp

Phase 2/3 Completed

151 enrolled 18 charts

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms

NCT00868998 2016-05-23

GTX Regimen for Biliary Cancers

Phase 2 Terminated

4 enrolled 7 charts

Gastrointestinal

Biliary Tract Neoplasms

NCT00338988 2012-08-01

Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma

Phase 2 Completed

44 enrolled 5 charts

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms